Haemophilus influenzae infection and Guillain-Barre syndrome

Brain

Volumn 123, Issue 10, 2000, Pages 2171-2178

  Mori, M ^a   Kuwabara, S ^a   Miyake, M ^a   Noda, M ^a   Kuroki, H ^a   Kanno, H ^a   Ogawara, K ^a   Hattori, T ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute motor axonal neuropathy; Anti GM1 antibody; Axonal degeneration; Guillain Barre syndrome; Haemophilus influenzae

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; GANGLIOSIDE GM1; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CAMPYLOBACTER JEJUNI; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HAEMOPHILUS INFLUENZAE; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NERVE FIBER DEGENERATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; WESTERN BLOTTING;

EID: 0033779231     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.10.2171     Document Type: Article

References (40)

1. Infections due to Haemophilus influenzae, HACEK group, Capnocytophaga, and H. ducreyi
2. Assessment of current diagnostic criteria for Guillain-Barre syndrome
3. Clinical and serological studies in a series of 45 patients with Guillain-Barre syndrome
4. Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis
5. Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barre syndrome) after immunization with Haemophilus influenzae type b conjugate vaccine
6. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barre syndrome and in other neuroimmunological disorders
7. Guillain-Barre syndrome following immunisation with Haemophilus influenzae type b conjugate vaccine
8. Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry
9. Haemophilus conjugate vaccine and Guillain-Barre syndrome
10. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections
11. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies
12. Controlled trial of prednisolone in acute polyneuropathy
13. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barre syndrome
14. The spectrum of antecedent infections in Guillain-Barre syndrome. A case-control study
15. Guillain-Barre syndrome and Campylobacter jejuni: A serological study
16. The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods
17. Guillain-Barre and Fisher's syndromes subsequent to Campylo-bacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies
18. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barre and Fisher's syndromes
19. Influence of age, gender and smoking on Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis antibody titres in an elderly population
20. Two patterns of clinical recovery in Guillain-Barre syndrome with IgG anti-GM1 antibody
21. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome
22. Cleavage of the structural proteins during the assembly of the head of bacteriophage T4
23. Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease
24. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated
25. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barre syndrome
26. Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain-Barre syndrome
27. Nontypable Haemophilus influenzae: A review of clinical aspects, surface antigens, and the human immune response to infection
28. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barre syndrome: Evidence of molecular mimicry
29. Anti-ganglioside GM1 antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection
30. Campylobacter jejuni infection and Guillain-Barre syndrome
31. Structural studies of the cell-envelope oligosaccharide from the lipopolysaccharide of Haemophilus influenzae strain RM.118-28
32. Guillain-Barre syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barre Study Group
33. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barre syndrome and controls: Correlation and prognosis
34. Bacterial lipopolysaccharides. Extraction with phenol-water and further application of the procedure
35. A prospective study of acute idiopathic neuropathy. II. Antecedent events
36. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis
37. Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barre syndrome: Molecular mimicry between ganglioside G(M1) and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni
38. Severe acute axonal form of Guillain-Barre syndrome associated with IgG anti-GD1a antibodies
39. A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure